Performance of cut-offs of the ASAS Health Index to discriminate between treatment groups in patients with axial spondyloarthritis in the TICOSPA trial
The data-driven thresholds of the ASAS HI identified in a longitudinal observational setting perform well in the context of a randomized trial.
Authors
- Uta Kiltz (ORCID: https://orcid.org/0000-0001-5668-4497)
- Clementina López‐Medina (ORCID: https://orcid.org/0000-0002-2309-5837)
- Annelies Boonen (ORCID: https://orcid.org/0000-0003-0682-9533)
- Filip Van den Bosch (ORCID: https://orcid.org/0000-0002-3561-5932)
- Anna Moltó (ORCID: https://orcid.org/0000-0003-2246-1986)
- Jürgen Braun (ORCID: https://orcid.org/0000-0002-9156-5095)
- Maxime Dougados (ORCID: https://orcid.org/0000-0003-3009-6229)
- Désirée M F M van der Heijde (ORCID: https://orcid.org/0000-0002-5781-158X)
Institutions
- Délégation Paris 5 (FR)
- Inserm (FR)
- Université Paris Cité (FR)
- Leiden University Medical Center (NL)
- Maastricht University Medical Centre (NL)
- Ghent University (BE)
- Maastricht University (NL)
- Sorbonne Paris Cité (FR)
- Rheumazentrum Ruhrgebiet (DE)
- Hôpital Cochin (FR)
- Instituto Maimónides de Investigación Biomédica de Córdoba (ES)
- Assistance Publique – Hôpitaux de Paris (FR)
- Center for HIV and Hepatogastroenterology (DE)
- VIB-UGent Center for Inflammation Research (BE)
- Centre de Recherche Épidémiologie et Statistique (FR)
- University of Córdoba (ES)
Publication Details
- Journal
- Seminars in Arthritis and Rheumatism
- Published
- 2024-08-30
- DOI
- https://doi.org/10.1016/j.semarthrit.2024.152542
- Citations
- 2
- Primary Topic
- Spondyloarthritis Studies and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.94